The Elixir Factor

As Lilly delivers medicines with speed and purpose, patient safety during clinical trials remains one of Lilly’s top priorities. This week, we welcome back our host Brian Winger, Lilly’s Associate Vice President, Digital Health Research and Development, Xiangnan Dang, Director of Engineering, and guests from Part 1, Tony Fantana and Chuck Benson. Guests on this episode will dive into the uniqueness of this technology; its effects and benefits to clinical trials; and, what’s next for Lilly in the future of clinical trials and monitoring for patient safety.

More than six million people currently live with Alzheimer’s disease and an additional five thousand are undiagnosed. Fighting and advocating for a disease without any treatment requires courage and resilience – as well as kindness and patience in the face of fear. On this episode of The Elixir Factor, Jim and Geri Taylor share their story of fighting this disease with courage and resilience, and finding ways to appreciate life together despite a chronic diagnosis.